Rise Advisors’s Rockwell Medical RMTI Stock Holding History

Rise Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22	Closed	-$258	–	1154
2025 Q3	$258	Hold	22	–	–	﹤0.01%	1464
2025 Q2	$182	Hold	22	–	–	﹤0.01%	1483
2025 Q1	$243	Hold	22	–	–	﹤0.01%	1431
2024 Q4	$439	Hold	22	–	–	﹤0.01%	1103
2024 Q3	$854	Hold	22	–	–	﹤0.01%	1169
2024 Q2	$378	Hold	22	–	–	﹤0.01%	1200
2024 Q1	$357	Hold	22	–	–	﹤0.01%	1226
2023 Q4	$406	Hold	22	–	–	﹤0.01%	575
2023 Q3	$447	Hold	22	–	–	﹤0.01%	585
2023 Q2	$1.17K	Hold	22	–	–	﹤0.01%	564
2023 Q1	$389	Sell	22 -101	-82%	-$1.74K	﹤0.01%	751
2022 Q4	$1.25K	Hold	123	–	–	﹤0.01%	630
2022 Q3	$2K	Sell	123 -18	-13%	-$273	﹤0.01%	567
2022 Q2	$2K	Hold	141	–	–	﹤0.01%	578
2022 Q1	$7K	Hold	141	–	–	0.01%	377
2021 Q4	$6.37K	Buy	+141	New	+$7.55K	0.01%	376

Other funds holding RMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rise Advisors's RMTI Position: Q4 2025 in Review

Rise Advisors sold out of Rockwell Medical (RMTI) in Q4 2025, closing a stake of 22 shares — an estimated $258 sold.

Rise Advisors first reported a position in RMTI in Q4 2021 and held it in 16 quarters. The position peaked at $7K in Q1 2022. 36 funds tracked by Wall St. Rank hold RMTI as of Q4 2025.

Rise Advisors reported no remaining Rockwell Medical position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 22 Rockwell Medical shares in Q4 2025, an estimated $258.
Rise Advisors first reported a position in Rockwell Medical in Q4 2021 and held it in 16 quarters.
Rise Advisors's Rockwell Medical position peaked at $7K in Q1 2022.
36 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.